Original title: A general framework for using two-stage meta-analysis with individual participant data to predict individualized treatment effects
Marta Mainetti, Konstantina Chalkou, Frederik Luca Philipona, Guido Schwarzer +2 · September 2026
Doctors want to predict individualized treatment effects, which means guessing how well a medical treatment will work for a specific person. Researchers often combine data from multiple medical trials using a two-stage method. In the past, this usually relied on standard regression equations. The researchers created a broader framework that allows scientists to use any statistical or machine learning tool to predict continuous outcomes. First, scientists build prediction models inside each trial separately. Second, they combine the results from all the trials to predict outcomes for new patients. To see how well this works, the team ran computer simulations. They found that machine learning performed best when sample sizes were large and the relationships were complex. However, regular regression performed better when the relationships were simple and linear. Because the true pattern in real data is unknown, researchers should test their models with internal validation before deciding which one to use.
Imagine you are a chef trying to perfect a recipe by tasting dishes from several different cooks. Each cook makes the dish slightly differently, and you want to know which ingredients matter most for each person's taste. The problem is that each cook's dish is only a small sample, and combining their recipes is tricky because they use different techniques. In this paper, the cooks are clinical trials, the recipes are treatment effects, and the framework tells you how to combine their results to predict what will work best for a new diner.
Doctors and researchers can now predict which patients benefit most from a treatment using any statistical or machine learning model, not just simple regression. This matters because the best method depends on the data: complex interactions need machine learning, while simple patterns are fine with regression. The framework gives clear guidance on how to combine results from multiple trials to make these predictions.
The framework does not identify which method is best for a given dataset without internal validation. The simulation study covered specific scenarios (continuous outcome, certain sample sizes, forms of effect modification), so results may not generalize to other settings like binary outcomes or different types of heterogeneity. The paper does not provide a definitive rule for choosing the first-stage model; it only shows relative performance in simulations.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
A general framework for using two-stage meta-analysis with individual participant data to predict individualized treatment effects — Marta Mainetti, Konstantina Chalkou, Frederik Luca Philipona et al. — BMC Medical Research Methodology — doi:10.1186/s12874-026-03002-z
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.